The efficacy of tolvaptan as a diuretic for chronic kidney disease patients

Tanaka Akihito; Katsuno Takayuki; Ozaki Takenori; Sakata Fumiko; Kato Noritoshi; Suzuki Yasuhiro; Kosugi Tomoki; Kato Sawako; Tsuboi Naotake; Sato Waichi; Yasuda Yoshinari; Mizuno Masashi; Ito Yasuhiko; Matsuo Seiichi; Maruyama Shoichi

首页> 外文期刊>Acta Cardiologica >The efficacy of tolvaptan as a diuretic for chronic kidney disease patients

【24h】

The efficacy of tolvaptan as a diuretic for chronic kidney disease patients

机译：托伐普坦作为利尿剂治疗慢性肾脏疾病患者的功效

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background Tolvaptan selectively binds to the vasopressin V2 receptor and inhibits reabsorption of free water. Although its efficacy for heart failure has been proven, its efficacy for chronic kidney disease (CKD) patients has not been assessed in detail.

机译：背景托伐普坦选择性结合血管加压素V2受体并抑制自由水的重吸收。尽管已证明其对心力衰竭的功效，但尚未详细评估其对慢性肾脏疾病（CKD）患者的功效。

著录项

来源
《Acta Cardiologica》 |2015年第2期|共7页
作者
Tanaka Akihito; Katsuno Takayuki; Ozaki Takenori; Sakata Fumiko; Kato Noritoshi; Suzuki Yasuhiro; Kosugi Tomoki; Kato Sawako; Tsuboi Naotake; Sato Waichi; Yasuda Yoshinari; Mizuno Masashi; Ito Yasuhiko; Matsuo Seiichi; Maruyama Shoichi;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词
Chronic kidney disease; CKD; tolvaptan; diuretic;

机译：慢性肾脏病;CKD;托伐普坦;利尿剂;

相似文献

外文文献
中文文献
专利

1. The efficacy of tolvaptan as a diuretic for chronic kidney disease patients [J] . Tanaka Akihito, Katsuno Takayuki, Ozaki Takenori, Acta Cardiologica . 2015,第2期

机译：托伐普坦作为利尿剂治疗慢性肾脏疾病患者的功效
2. Efficacy of Long‐Term Treatment With Tolvaptan to Prolong the Time Until Dialysis Initiation in Patients With Chronic Kidney Disease and Heart Failure [J] . Tanaka Akihito, Hiramatsu Emiko, Watanabe Yu, Therapeutic apheresis and dialysis: official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy . 2019,第4期

机译：长期治疗与托尔沃坦治疗延长慢性肾病和心力衰竭患者透析透析效果的功效
3. Safety and Efficacy of Long-Term Use of Tolvaptan in Patients With Heart Failure and Chronic Kidney Disease [J] . Yusuke Uemura, Rei Shibata, Kenji Takemoto, Circulation journal . 2017,第11期

机译：长期使用托伐普坦治疗心力衰竭和慢性肾脏病患者的安全性和有效性
4. The Natural History of Chronic Kidney Disease Revisited-A 72-Month Mayo Health System Hypertension Clinic Practice-Based Research Network Prospective Report on End-Stage Renal Disease and Death Rates in 100 High-Risk Chronic Kidney Disease Patients: A Call for Circumspection [C] . Macaulay A.C. Onuigbo Conference on Peritoneal Dialysis . 2009

机译：慢性肾病的自然历史重新审议-A 72个月的MASO卫生系统高血压诊所的研究网络网络前期肾病和死亡率100个高危慢性肾病患者的死亡率：一个呼吁守则
5. Subtyping Chronic Kidney Disease Patients and Adiposity-Obesity Related Metabolomics Analyses: Findings from the Chronic Renal Insufficiency Cohort Study [D] . Zheng, Zihe. 2021

机译：亚型慢性肾病患者和肥胖肥胖相关的代谢组科分析：从慢性肾功能不全的研究结果研究
6. Safety and Efficacy of Tolvaptan for the Prevention of Contrast-Induced Acute Kidney Injury in Patients with Heart Failure and Chronic Kidney Disease [O] . Kennosuke Yamashita, Wataru Igawa, Morio Ono, 2019

机译：托伐普坦预防心力衰竭和慢性肾脏病患者造影剂引起的急性肾脏损伤的安全性和有效性
7. The Efficacy and Renal Protective Effect of Tolvaptan in Chronic Kidney Disease Patients after Open-Heart Surgery [O] . Yasuhiro Futamura, Hirotaka Watanuki, Masaho Okada, 2021

机译：肺部手术后慢性肾病患者托尔瓦膜在慢性肾病患者的疗效和肾保护作用

The efficacy of tolvaptan as a diuretic for chronic kidney disease patients

摘要

著录项

相似文献

相关主题

期刊订阅